Combination Therapy for Overactive Bladder: Should We Define Refractoriness?
- PMID: 31540792
- DOI: 10.1016/j.eururo.2019.09.003
Combination Therapy for Overactive Bladder: Should We Define Refractoriness?
Comment on
-
Efficacy and Safety of Combination Pharmacotherapy for Patients with Overactive Bladder: A Rapid Evidence Assessment.Eur Urol. 2019 Dec;76(6):767-779. doi: 10.1016/j.eururo.2019.07.010. Epub 2019 Aug 13. Eur Urol. 2019. PMID: 31416636 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
